<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; myocardial ischemia;</title>
	<atom:link href="http://www.straightstocks.com/tag/myocardial-ischemia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Sat, 20 Mar 2010 02:36:07 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>DrStockPick.com Stock Report! 9/14/09, BSI, NFRX, TEVE, NIMU, PER</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-bsi-nfrx-teve-nimu-per/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-bsi-nfrx-teve-nimu-per/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 17:57:48 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[angina]]></category>
		<category><![CDATA[Barcelona]]></category>
		<category><![CDATA[Blue Square Israel Ltd]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[coronary artery disease]]></category>
		<category><![CDATA[Dave Marchand]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[European Society of Cardiology;]]></category>
		<category><![CDATA[healthcare leaders;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[InferX Corporation]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[KG Information Systems Limited]]></category>
		<category><![CDATA[Kyoto]]></category>
		<category><![CDATA[Marvin A Sackner]]></category>
		<category><![CDATA[myocardial ischemia;]]></category>
		<category><![CDATA[Non-Invasive Monitoring Systems Inc.]]></category>
		<category><![CDATA[Osaka]]></category>
		<category><![CDATA[perfume products]]></category>
		<category><![CDATA[Perot Systems Corporation]]></category>
		<category><![CDATA[server software;]]></category>
		<category><![CDATA[software release]]></category>
		<category><![CDATA[TelVue  Princeton(TM)]]></category>
		<category><![CDATA[TelVue Corporation]]></category>
		<category><![CDATA[TelVue Princeton]]></category>
		<category><![CDATA[Tim Quigley]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3380</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Monday September 14, 2009



**************************************************************

Blue Square-Israel Ltd.  (NYSE: BSI) announced that it was served with a claim and a request for  approval as a class action (the &#8220;Claim&#8221;), in which Blue Square is being sued  regarding the sale of cosmetics and perfume products without marking the expiry  date or [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-bsi-nfrx-teve-nimu-per/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM</title>
		<link>http://www.straightstocks.com/financial/fda-clinical-trial-updates-jnj-incy-medx-cytx-agn-pphm/</link>
		<comments>http://www.straightstocks.com/financial/fda-clinical-trial-updates-jnj-incy-medx-cytx-agn-pphm/#comments</comments>
		<pubDate>Tue, 02 Jun 2009 16:00:58 +0000</pubDate>
		<dc:creator>Bullish Bankers</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[3Q08;]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[Allergan Inc.;]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Botox;]]></category>
		<category><![CDATA[BOTOX®;]]></category>
		<category><![CDATA[Brain Cancer]]></category>
		<category><![CDATA[bullish bankers]]></category>
		<category><![CDATA[cerebral palsy;]]></category>
		<category><![CDATA[chTNT-1/B;]]></category>
		<category><![CDATA[deep vein thrombosis]]></category>
		<category><![CDATA[essential thrombocythemia;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[FDA Advisory Panel;]]></category>
		<category><![CDATA[Glioblastoma Multiforme]]></category>
		<category><![CDATA[Glioma;]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[INCB18424;]]></category>
		<category><![CDATA[Incyte Corp;]]></category>
		<category><![CDATA[Johnson]]></category>
		<category><![CDATA[Mike Havrilla]]></category>
		<category><![CDATA[myelofibrosis;]]></category>
		<category><![CDATA[myocardial ischemia;]]></category>
		<category><![CDATA[polycythemia vera;]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[pulmonary embolism]]></category>
		<category><![CDATA[Society of Nuclear Medicine Annual;]]></category>
		<category><![CDATA[stroke]]></category>
		<category><![CDATA[the Society;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.bullishbankers.com/?p=14068</guid>
		<description><![CDATA[Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/financial/fda-clinical-trial-updates-jnj-incy-medx-cytx-agn-pphm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
